Global Hemophilia Therapeutics Market to Reach US$ 13 Billion by 2022

"Grants and tax credits, rising healthcare expenditure, and increasing awareness about hemophilia likely to drive the Global Hemophilia Therapeutics Market", says RNCOS.

RNCOS LogoRNCOS Logo

Noida, Uttar Pradesh, June 21, 2017 /India PRwire/ -- Hemophilia is an inherited bleeding disorder in which a person lacks or has low levels of certain proteins, known as clotting factors. This leads to excessive bleeding in patients. Hemophilia is a chronic disease which can last for a very long time of a patient's life. According to World Federation of Hemophilia, about 1 in 10,000 people are born with this disease. The treatment of hemophilia requires the use of drugs, which can be administered intravenously.

According to our report, "Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate, Feiba), By Type of Hemophilia, By Treatment (On-Demand, Prophylaxis), By Therapy (Replacement, Immune Tolerance Induction) Outlook 2022", the Global Hemophilia Therapeutics Market is expected to grow at a CAGR of around 5% from 2016 - 2022. The market segmentations by type of hemophilia, by type of treatment, by type of therapy and by geography have been mentioned in the report. The global hemophilia therapeutics market has been segmented on the basis of type of hemophilia into hemophilia A, hemophilia B and others. According to the report, the treatment for hemophilia can be on-demand treatment or prophylaxis treatment. Furthermore, hemophilia can be treated by replacement therapy and immune tolerance induction therapy. Moreover, pharmaceutical and biotech companies are also developing gene therapy for the treatment of this condition.

Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America accounted for the largest share in the global market for hemophilia drugs. Moreover, the report also highlights various mergers and acquisitions taking place in the global hemophilia therapeutics industry. Pipeline of hemophilia drugs have also been mentioned in the report.

The report also covers the key players of the Global Hemophilia Therapeutics Market. For every player, a brief business overview and key financials has been provided. The product portfolio, product pipeline and recent developments of each player have also been listed down. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Global Hemophilia Therapeutics Market.

Some of the key findings of the report are:

  • Incessant Launch of New Generation of Recombinant Factor Products

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM911.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

Notes to Editor

About RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.


Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


RNCOS E-Services Pvt. Ltd. recent press release(s)


RNCOS White Paper: The Indian Health Insurance Sector

"The standalone health insurance industry continues to show the fastest growth rate on account of constant innovation by the players, says RNCOS"

Global Parkinson's Disease Drugs Market to Reach Approximate Value of US$ 5 Billion by 2022

"Growing aged population, rising healthcare expenditure, and increasing awareness about Parkinson's disease treatment options, likely to drive the Global Parkinson's Disease Drugs Market", says RNCOS.

Increasing Consumer Preference of Healthy Snacks Propelling Gourmet Popcorn Industry

Gourmet popcorns are becoming the consumers preference as a healthy snacks, says RNCOS in its latest research report.

Usage of Nanomaterial Propelling the Europe Cosmeceutical Market

Increased usage of nonmaterial in cosmetic products is driving the cosmeceutical market, says RNCOS in its latest research report.

Government Initiatives Driving Warehouse Industry

Increasing government initiatives encouraging domestic and foreign investments, says RNCOS in its latest report.